[HTML][HTML] Symptomatic protective action of glycyrrhizin (licorice) in COVID-19 infection?

H Murck - Frontiers in immunology, 2020 - frontiersin.org
The role of the ACE2 enzyme in the COVID-19 infection is 2-fold, with opposing implications
for the disease development. 1. The membrane bound angiotensin converting enzyme 2 …

[HTML][HTML] Traditional uses, pharmacological effects, and molecular mechanisms of licorice in potential therapy of COVID-19

Q Zhang, H Huang, M Qiu, Z Wu, Z Xin, X Cai… - Frontiers in …, 2021 - frontiersin.org
The current Coronavirus disease 2019 (COVID-19) pandemic has become a global
challenge, and although vaccines have been developed, it is expected that mild to moderate …

[HTML][HTML] The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions

AA Gomaa, YA Abdel-Wadood - Phytomedicine plus, 2021 - Elsevier
Background Several recent studies have stated that glycyrrhizin and licorice extract are
present in most traditional Chinese medicine formulas used against SARS-CoV-2 in China …

Glycyrrhizin: An old weapon against a novel coronavirus

J Chrzanowski, A Chrzanowska… - Phytotherapy …, 2021 - Wiley Online Library
Currently, over 100 countries are fighting against a common enemy, the severe acute
respiratory syndrome coronavirus (SARS‐CoV)‐2, which causes COVID‐19. This has …

[HTML][HTML] Glycyrrhizic acid: a natural plant ingredient as a drug candidate to treat COVID-19

Z Sun, G He, N Huang, K Thilakavathy… - Frontiers in …, 2021 - frontiersin.org
The total number of cumulative cases and deaths from the COVID-19 pandemic caused by
SARS-CoV-2 is still increasing worldwide. Although many countries have actively …

[HTML][HTML] EGCG, a green tea catechin, as a potential therapeutic agent for symptomatic and asymptomatic SARS-CoV-2 infection

M Chourasia, PR Koppula, A Battu, MM Ouseph… - Molecules, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has emerged to be the greatest threat to humanity in the …

[HTML][HTML] Protective effect of epigallocatechin-3-gallate (EGCG) in diseases with uncontrolled immune activation: could such a scenario be helpful to counteract COVID …

M Menegazzi, R Campagnari, M Bertoldi… - International Journal of …, 2020 - mdpi.com
Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia which can
result in a cytokine storm syndrome in response to Severe Acute Respiratory Syndrome …

Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19

P Luo, D Liu, J Li - International Journal of Antimicrobial Agents, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) caused by the previously unknown
pathogen, severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) is now a …

[HTML][HTML] Potential of herbal products in prevention and treatment of COVID-19. Literature review

A Gajewski, A Kośmider, A Nowacka, O Puk… - Biomedicine & …, 2021 - Elsevier
The COVID-19 epidemic is the greatest pandemic that human kind experienced for decades,
with high morbidity and mortality. Despite recent development of vaccines there is still many …

[HTML][HTML] Can antiviral activity of licorice help fight COVID-19 infection?

L Diomede, M Beeg, A Gamba, O Fumagalli, M Gobbi… - Biomolecules, 2021 - mdpi.com
The phytotherapeutic properties of Glycyrrhiza glabra (licorice) extract are mainly attributed
to glycyrrhizin (GR) and glycyrrhetinic acid (GA). Among their possible pharmacological …